All lobbying filings

FORBES-TATE

Lobbying for ANTIMICROBIAL INNOVATION ALLIANCE · Development of antimicrobial resistance policy to assist life sciences industry.

Filing Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 19, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to the development of critical need antimicrobial biopharmaceuticals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.